Evidence map›Paper›PMID 36835287›Full record

ArticleInternational journal of molecular sciences2023

Pre-Diabetes-Linked miRNA miR-193b-3p Targets PPARGC1A, Disrupts Metabolic Gene Expression Profile and Increases Lipid Accumulation in Hepatocytes: Relevance for MAFLD.

Inês Guerra Mollet, Maria Paula Macedo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Circulating microRNA Biomarkers of Thiazide Response in Hypertension.Journal of the American Heart Association · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Inês Guerra MolletiNOVA4Health, NOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa, 1150-082 Lisboa, Portugal.ORCID 0000-0002-1422-1336
Maria Paula MacedoiNOVA4Health, NOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa, 1150-082 Lisboa, Portugal.ORCID 0000-0002-2549-0275
Associacao Protectora dos Diabeticos de Portugal · PTUniversidade Nova de Lisboa · PT

Funding

European Commission Marie Skłodowska-Curie Actions H2020 Grant No. 734719Fundação para a Ciência e Tecnologia PTDC/BIM-MET/2115/2014Fundação para a Ciência e Tecnologia PTDC/MEC-MET/29314/2017Fundação para a Ciência e Tecnologia UID/Multi/04462/2013
6 · The paper itself

Abstract

Distinct plasma microRNA profiles associate with different disease features and could be used to personalize diagnostics. Elevated plasma microRNA hsa-miR-193b-3p has been reported in patients with pre-diabetes where early asymptomatic liver dysmetabolism plays a crucial role. In this study, we propose the hypothesis that elevated plasma hsa-miR-193b-3p conditions hepatocyte metabolic functions contributing to fatty liver disease. We show that hsa-miR-193b-3p specifically targets the mRNA of its predicted target

Indexed as

HepatocytesLiver DiseasesMicroRNAsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPrediabetic StateHumansIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTranscriptomeIntracellular Signaling Peptides and ProteinsMicroRNAsMIRN193 microRNA, humanPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanProtein Serine-Threonine KinasesTRIB1 protein, humanhsa-miR-193b-3plipid metabolismlivermetabolic syndromeperoxisome proliferator activated receptor gamma coactivator 1 alpha

Identifiers

PMID36835287
PMCPMC9965679
OpenAlexW4320920075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.